|
Efficacy Of Acitretin In Management Of Acrodermatitis Continua Of Hallopeau And Consequence Of Medication Non-Adherence In Ach: A Case Report
|
|
| Author:
|
KALA BAHADUR RAWAL, A. ASHVIL, S. ANUSHA, MIN BAHADUR LUHAR, RLN MURTHY, P. KRISHNAVENI, VIBITHA VINOD, ASHISH GIRI, LAVANYA VOORA, RAMESH BHANDARI
|
| Abstract:
|
Introduction: Acrodermatitis Continua of Hallapeau (ACH) is a rare chronic inflammatory disease condition characterized by the sterile pustular eruption of fingers, toes, and nails. There is very less evidence on standard treatment of ACH, but it can be managed with conventional anti-psoriatic therapy as well as newer agents like the biological products.
Case presentation: a 69 years old female patient admitted to female skin ward unit B with a known case of Acrodermatitis Continua of Hallapeau and on treatment since last five months, the patient was maintaining well with tablet Acitretin 25mg, due to the financial problem she was unable to continue medication as per the advice of a physician and discontinued the therapy after 40 days. The ACH condition relapsed more aggressively, resulting in the hospitalization of the patient.
Treatments: The patient was treated with conventional anti-psoriatic therapy, systemic and topical antibiotics, emollients, antiallergic, antipyretic, calcium and vitamin D3 supplements, and saline compression during the rehospitalization.
Conclusion: Safe, effective, and low-cost therapy can prevent the incidence of relapse. Hence, adequate counseling from a clinical pharmacist can help in speedy recovery and prevention of hospitalization.
|
| Keyword:
|
Conventional anti-psoriatic therapy, Pustules, counseling, patient education, low-cost therapy, medication adherence
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2020.SP2.010
|
| Download:
|
Request For Article
|
|
|